PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Phenotype | C0153687|skin metastases |
| Sentences | 5 |
| PubMedID- 22767669 | Topical tlr7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. |
| PubMedID- 24158082 | In advanced breast cancer patients with skin metastases overexpressing her2, previously treated with anthracyclines, taxanes and trastuzumab, lapatinib and capecitabine may represent a very active, safe and well-tolerated treatment option. |
| PubMedID- 23853494 | Therefore, the skin metastases of breast cancer and lung cancer have been more common than those of intra-abdominal organ cancer in the past two decades, although the incidence of primary cancer from an intra-abdominal organ is much higher than that from the breast cancer and lung cancer. |
| PubMedID- 22068139 | Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy. |
| PubMedID- 24641425 | Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments. |
Page: 1